Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100227696 | 10022769 | 6 | F | 20111215 | 20160412 | 20140319 | 20160720 | EXP | US-DAIICHI SANKYO EUROPE GMBH-DSU-2014-100592 | DAIICHI | 68.42 | YR | M | Y | 81.18000 | KG | 20160720 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100227696 | 10022769 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25 MG, QAM | 1185 | DF | Y | 21532 | FILM-COATED TABLET | QD | |||||
| 100227696 | 10022769 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25 MG, 1 TAB QD | 1185 | DF | Y | 21532 | FILM-COATED TABLET | QD | |||||
| 100227696 | 10022769 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG | 1185 | DF | Y | 21532 | 1 | DF | FILM-COATED TABLET | |||||
| 100227696 | 10022769 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25 MG, 1 TAB, QD | 1185 | DF | Y | 21532 | 1 | DF | FILM-COATED TABLET | QD | |||
| 100227696 | 10022769 | 5 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 100227696 | 10022769 | 6 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 0 | TABLET | |||||||||
| 100227696 | 10022769 | 7 | C | TENORMIN | ATENOLOL | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 100227696 | 10022769 | 9 | C | EPLERENONE. | EPLERENONE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | QD | |||||||
| 100227696 | 10022769 | 10 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 100227696 | 10022769 | 11 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 12 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 13 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 14 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, UNK | 0 | 60 | MG | QD | ||||||||
| 100227696 | 10022769 | 15 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0.075 MG, QD | 0 | .075 | MG | QD | |||||||
| 100227696 | 10022769 | 16 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, QD | 0 | 81 | MG | QD | ||||||||
| 100227696 | 10022769 | 17 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1 TABLET, QD | 0 | 1 | DF | QD | |||||||
| 100227696 | 10022769 | 18 | C | PREVACID | LANSOPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 100227696 | 10022769 | 19 | C | ZOCOR | SIMVASTATIN | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 20 | C | LORAZEPAM. | LORAZEPAM | 1 | 2 MG, PRN Q HS | 0 | 2 | MG | |||||||||
| 100227696 | 10022769 | 21 | C | XALATAN | LATANOPROST | 1 | 0 | ||||||||||||
| 100227696 | 10022769 | 22 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 100227696 | 10022769 | 23 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 20 MG, QD | 0 | 20 | MG | TABLET | QD | |||||||
| 100227696 | 10022769 | 24 | C | ZETIA | EZETIMIBE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 100227696 | 10022769 | 25 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 2000 IU, UNK | 0 | 2000 | IU | QD | ||||||||
| 100227696 | 10022769 | 26 | C | CENTRUM SILVER /02363801/ | MINERALSVITAMINS | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 100227696 | 10022769 | 27 | C | BRIMONIDINE /01341102/ | 2 | Ophthalmic | 0 | ||||||||||||
| 100227696 | 10022769 | 28 | C | TIMOLOL. | TIMOLOL | 1 | Ophthalmic | 0.5 %, UNK | 0 | .5 | PCT | ||||||||
| 100227696 | 10022769 | 29 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Nasal | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100227696 | 10022769 | 1 | Hypertension |
| 100227696 | 10022769 | 5 | Hypertension |
| 100227696 | 10022769 | 7 | Hypertension |
| 100227696 | 10022769 | 8 | Hypertension |
| 100227696 | 10022769 | 9 | Hypertension |
| 100227696 | 10022769 | 10 | Hypertension |
| 100227696 | 10022769 | 11 | Depression |
| 100227696 | 10022769 | 12 | Depression |
| 100227696 | 10022769 | 13 | Depression |
| 100227696 | 10022769 | 14 | Depression |
| 100227696 | 10022769 | 15 | Thyroid cancer |
| 100227696 | 10022769 | 16 | Product used for unknown indication |
| 100227696 | 10022769 | 17 | Product used for unknown indication |
| 100227696 | 10022769 | 18 | Product used for unknown indication |
| 100227696 | 10022769 | 19 | Product used for unknown indication |
| 100227696 | 10022769 | 20 | Product used for unknown indication |
| 100227696 | 10022769 | 21 | Product used for unknown indication |
| 100227696 | 10022769 | 22 | Product used for unknown indication |
| 100227696 | 10022769 | 23 | Product used for unknown indication |
| 100227696 | 10022769 | 24 | Product used for unknown indication |
| 100227696 | 10022769 | 25 | Product used for unknown indication |
| 100227696 | 10022769 | 26 | Product used for unknown indication |
| 100227696 | 10022769 | 27 | Product used for unknown indication |
| 100227696 | 10022769 | 28 | Product used for unknown indication |
| 100227696 | 10022769 | 29 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100227696 | 10022769 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100227696 | 10022769 | Ageusia | |
| 100227696 | 10022769 | Anosmia | |
| 100227696 | 10022769 | Contusion | |
| 100227696 | 10022769 | Diverticulum intestinal | |
| 100227696 | 10022769 | Duodenal ulcer | |
| 100227696 | 10022769 | Gastrointestinal bacterial overgrowth | |
| 100227696 | 10022769 | Haematuria | |
| 100227696 | 10022769 | Haemorrhoids | |
| 100227696 | 10022769 | Hepatic steatosis | |
| 100227696 | 10022769 | Incontinence | |
| 100227696 | 10022769 | Malabsorption | |
| 100227696 | 10022769 | Nocturia | |
| 100227696 | 10022769 | Red blood cell sedimentation rate increased | |
| 100227696 | 10022769 | Renal cyst | |
| 100227696 | 10022769 | Renin decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100227696 | 10022769 | 1 | 200812 | 20120403 | 0 | |
| 100227696 | 10022769 | 2 | 2012 | 0 | ||
| 100227696 | 10022769 | 3 | 20080914 | 0 | ||
| 100227696 | 10022769 | 4 | 20080917 | 20120403 | 0 | |
| 100227696 | 10022769 | 5 | 20080908 | 20120403 | 0 | |
| 100227696 | 10022769 | 6 | 20080926 | 0 |